1. Home >
  2. M&A >
  3. Buyout (LBO, MBO, MBI) >
  4. Sweden >
  5. MedCap Acquires Unimedic Pharma

M&A Deal Summary

MedCap Acquires Unimedic Pharma

On October 1, 2006, private equity firm MedCap acquired life science company Unimedic Pharma

Acquisition Highlights
  • This is MedCap’s 1st transaction in the Life Science sector.
  • This is MedCap’s 1st transaction in Sweden.

M&A Deal Summary
Date 2006-10-01
Target Unimedic Pharma
Sector Life Science
Buyer(s) MedCap
Deal Type Buyout (LBO, MBO, MBI)

Target

Unimedic Pharma

Stockholm, Sweden
Unimedic Pharma is a fully integrated Swedish specialty pharma company with broad experience in drug development, distribution, and marketing of pharmaceuticals. Unimedic Pharma supplies the Nordics and Northern Europe with a wide range of medicines in several therapeutic areas. Unimedic Pharma was founded in 1992 and is based in Stockholm, Sweden.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

MedCap

Category Private Equity Firm
Size Small
Type Sector Focused
DESCRIPTION

MedCap is a publicly traded investment firm focused on acquiring and developing medical technology and life science companies in Northern Europe. The Firm targets businesses with 50 to 200 MSEK. MedCap was established in 2001 and is headquartered in Solna, Sweden.

DEAL STATS #
Overall 1 of 5
Sector: Life Science M&A 1 of 1
Type: Buyout (LBO, MBO, MBI) M&A Deals 1 of 4
Country: Sweden M&A 1 of 3
Year: 2006 M&A 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-02-02 Inpac

Lund, Sweden

Inpac is a Nordic company with experience and expertise in packaging and contract manufacturing of pharmaceuticals, probiotics and nutritional products. Inpac was founded in 1948 and is based in Lund, Sweden.

Buy -
Mergr

Solution for

Product

Company

Legal